All Clinical Resources

1 - 12 of 225 results

Uncontrolled Asthma

Podcast Series Sponsored by GlaxoSmithKline; Not for CME/CE Credit


Early Detection of Pancreatic Cancer: The Importance of Primary Care

Podcast Series Sponsored by Immunovia; Not for CME/CE Credit


CDC Resource: COVID-19 and HIV

CDC Resources for Health Care Providers

CDC Resources for Health Care Providers


FAQ for HIV Update for the Non-ID Specialist: What Every Clinician Needs to Know

This case-based, interactive lecture will cover the current epidemiology of HIV in the United States, and then focus on issues critical for the primary care provider - HIV testing, identification of acute infection, initiating a baseline work-up, and understanding the basics of antiretroviral therapy. HIV prevention will be covered citing both the pre- and post-exposure prophylaxis strategies.Guest: Paul E. Sax, MD

This case-based, interactive lecture will cover the current epidemiology of HIV in the United States, and then focus on issues critical for the primary care provider - HIV testing, identification of acute infection, initiating a baseline work-up, and understanding the basics of antiretroviral therapy. HIV prevention will be covered citing both the pre- and post-exposure prophylaxis strategies.


FAQ for To Be or Not to Be Gluten Free: Food Elimination Diets for Allergies, Intolerances and Wellness

Increasing numbers of patients are talking with their health care professionals about specialized diets and testing for allergies and food sensitivities as part of their overall wellness plan. Good diet quality is a well-recognized element of lifestyle medicine, but there is growing confusion among medical professionals and consumers about "good" foods and if they should eliminate certain foods from their diet. This talk will cover several of the popular media approaches to healthy living, including diets like Gluten Free, Whole 30, Ketogenic, as well as relevant data for health-related outcomes for each. The differences between allergic bowel disorders and intolerances will be discussed. Clinical and nutritional counseling tips will be provided.Guest: Bethany Doerfler, MS, RDN

Increasing numbers of patients are talking with their health care professionals about specialized diets and testing for allergies and food sensitivities as part of their overall wellness plan. Good diet quality is a well-recognized element of lifestyle medicine, but there is growing confusion among medical professionals and consumers about "good" foods and if they should eliminate certain foods from their diet. This talk will cover several of the popular media approaches to healthy living, including diets like Gluten Free, Whole 30, Ketogenic, as well as relevant data for health-related outcomes for each. The differences between allergic bowel disorders and intolerances will be discussed. Clinical and nutritional counseling tips will be provided.


FAQ for Medical Marijuana: Weeding Fact from Fiction

This talk will review the impact of cannabis use and legalization of it in clinical practice.Guest: Panagiota Caralis, MD, JD, FACP

This talk will review the impact of cannabis use and legalization of it in clinical practice.


The Clinical Progression of Heart Failure: Can You Recognize the Signs of Worsening Disease?

Industry Podcast Sponsored by Novartis Pharmaceuticals Corporation; Not for CME/CE Credit

The clinical course of heart failure is progressive and often involves periods of disease worsening that can be challenging to identify for both patients and their health care providers.1-4 In this episode, featuring cardiologist Dr Lee Goldberg of the University of Pennsylvania, we will discuss key aspects of the clinical assessment of heart failure worsening and progression in the outpatient setting and emphasize the importance of optimizing guideline-directed medical therapy in patients with worsening heart failure as well as in those with stable disease.


FAQ for the Pharmacotherapy of Alcohol and Opioid Use Disorders

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.Guest: Petros Levounis, MD, MA

In the U.S., about 15.1 million people have an alcohol use disorder and about 4.8 million misuse opioids. This session focuses on the pharmacotherapy of alcohol and opioid use disorders. The faculty will describe and contrast naltrexone and acamprosate treatments for alcohol use disorder and discuss the use of buprenorphine/naloxone to treat opioid use disorder.


FAQ for What's New in Obesity Management?

Guest: Robert F. Kushner, MD, FACP